AI in Telehealth & Telemedicine Market by Component (Software, Service), Function (Virtual Care, Chatbot, RPM, Admin, Patient Engagement), Application (Teleneurology, TeleICU, Teleradiology), End User (Provider, Payer, Patient) - Global Forecast to 2030

icon1
USD 27.14 BN
MARKET SIZE, 2030
icon2
CAGR 36.4%
(2025-2030)
icon3
385
REPORT PAGES
icon4
409
MARKET TABLES

OVERVIEW

AI in Telehealth & Telemedicine Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The AI in telehealth and telemedicine market size is projected to reach USD 27.14 billion by 2030 from USD 6.17 billion in 2025, at a CAGR of 36.4% during the forecast period. The market has experienced significant growth primarily driven by the growing geriatric and medically underserved (predominantly rural) population, the increasing prevalence of chronic conditions, the shortage of physicians and care personnel, advancements in telecommunication technologies, and the expansion of RPM systems.

KEY TAKEAWAYS

  • North America is estimated to dominate the AI in telehealth & telemedicine market with a share of 50.4% in 2024.
  • By component, the software segment accounted for a share of 70.4% in terms of value in 2024.
  • By function, the remote patient monitoring segment is projected to grow at a CAGR of 38.4% during the forecast period.
  • By application, the primary care segment is expected to hold the largest shar for the AI in telehealth & telemedicine market in 2024.
  • By end user, the healthcare providers segment accounted for the largest market size in 2024.
  • Medtronic, GE Healthcare, Oracle, and Koninklijke Philips N.V. were identified as Star players in the AI in telehealth & telemedicine market, given their broad industry coverage and strong operational & financial strength.
  • K Health, Andor Health, and BioIntelliSense, Inc. have distinguished themselves among startups and SMEs due to their well-developed marketing channels and extensive funding to build their product portfolio

The AI in telehealth & telemedicine market is projected to reach USD 27.14 billion by 2030 from USD 4.22 billion in 2024, at a CAGR of 36.4% from 2024 to 2030

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

In the AI in telehealth and telemedicine market, the impact on consumers’ businesses results from evolving customer trends and technological disruptions. Hot prospects include healthcare providers, payers, and enterprises that are adopting AI-enabled telehealth platforms. Target applications encompass virtual care delivery, remote patient monitoring (RPM), AI-driven diagnostics, clinical decision support, and workflow automation tools. Shifts such as AI integration, cloud-based telehealth expansion, evolving reimbursement policies, interoperability requirements, and the transition toward value-based care models influence the revenues of end users like hospitals, clinics, and home care providers. These changes in end-user revenues directly affect the revenue of hot prospects, ultimately impacting the performance of AI in telehealth and telemedicine vendors such as GE Healthcare, Epic Systems, Medtronic, Oracle, and Philips.

AI in Telehealth & Telemedicine Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing adoption of virtual assistant chatbots
  • Rising popularity of e-prescriptions
RESTRAINTS
Impact
Level
  • Regulatory variations across regions
  • Lack of advanced telemedicine infrastructure in emerging economies
OPPORTUNITIES
Impact
Level
  • Growing popularity of virtual healthcare solutions
  • Emergence of AI and ML.
CHALLENGES
Impact
Level
  • Increasing data breaches and medical identity theft cases
  • Complexities of big data in healthcare

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing adoption of virtual assistant chatbots

The adoption of virtual assistant chatbots for Al-based telemedicine solutions has a significant share due to an increased demand for accessible healthcare and operational efficiency. Chatbots in telemedicine leverage Al technologies such as NLP and ML to provide personalized and efficient healthcare services. They offer 24/7 support, answering patient queries and guiding them to appropriate medical resources. Chatbots assess symptoms based on extensive medical databases, determining whether patients need urgent care or can manage their conditions independently. For instance, in January 2023, Northwell Health Solutions (US) implemented Northwell Health Pregnancy Health Chats, an Al-driven pregnancy chatbot for obstetrics practices. Furthermore, Boston Children Hospital employs a KidsMD chatbot that assists parents in making an appointment by analyzing their child's symptoms and determining whether one is required.

Restraint: Regulatory variations across regions

The regulatory landscape for AI-based telemedicine presents significant obstacles that limit its market expansion. Different regions adopt varied approaches to regulating AI within healthcare, reflecting diverse strategies for integrating AI technologies. In Australia, the Therapeutic Goods Administration (TGA) oversees AI-driven medical devices, focusing on risk-based classification and patient safety concerns. China's NMPA has issued guidelines for AI-assisted software, prioritizing classification, safety, and efficacy standards to create uniform regulations domestically and globally. Southeast Asian nations like India and Indonesia have their own telemedicine regulations that cover consent, data security, and platform requirements; for example, India's rules mandate registered medical practitioners and grievance procedures. Meanwhile, in Europe and the US, regulatory frameworks like GDPR and HIPAA are continually evolving to protect patient data privacy and security.

Opportunity: Emergence of AI and ML

The integration of AI and ML is a key driver in the telehealth and telemedicine market, transforming healthcare and improving patient outcomes. AI allows remote patient monitoring (RPM), enabling providers to track vital signs and health metrics continuously without frequent visits. AI-powered devices collect real-time data on heart rate, blood pressure, and glucose, allowing proactive care and early detection of issues, enhancing efficiency, safety, and satisfaction. For example, in December 2024, NHS Lothian launched the UK's first AI-powered physiotherapy clinic, Flok Health, to address high musculoskeletal waitlists. The platform provides same-day automated video appointments with an AI physiotherapist via a smartphone app. These advances in AI and ML drive market growth.

Challenge: Increasing data breaches and medical identity theft cases

In healthcare, approximately one-third of data breaches result in medical identity theft mainly due to a lack of internal control over patient information, a lack of top management support, outdated policies and procedures or non-adherence to existing ones, and inadequate personnel training, all of which contribute to the rise in data breaches and medical identity theft cases in the industry, making patient confidentiality a significant challenge in the healthcare industry. Patient data contains personal, private, or confidential information requiring strict safeguards to prevent misuse. The growing use of automated technologies (such as EHRs and medical claims processing) and the shifting trend toward health information exchanges (HIEs) have altered the healthcare privacy and security landscape. The electronic exchange of patient data offers greater reach and efficiency in healthcare delivery. Still, it involves greater data risk and liability due to broader access and can result in data breaches.

AI in Telehealth & Telemedicine Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Deploys AI-enabled remote diagnostics and imaging-as-a-service platforms that help healthcare enterprises and clinics access advanced imaging analytics. Enables faster, more accurate diagnostic decisions while reducing dependence on in-person imaging specialists and optimizing resource use
Offers end-to-end telehealth platforms and connected monitoring devices for hospitals and home care settings to support hybrid care delivery Expands patient access to care, boosts engagement and adherence, and reduces hospital burden through remote service delivery
Provides a cloud-based clinical and claims data platform to enable virtual care management, payer analytics, and telehealth integration Streamlines reimbursement, improves interoperability, and accelerates data-driven decisions across payers and providers
Uses connected medical devices and AI analytics for continuous remote patient monitoring across cardiac, diabetic, and respiratory conditions Enhances chronic disease management, reduces emergency visits, and enables proactive care through predictive insights

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

Al in telehealth & telemedicine has revolutionized healthcare by facilitating remote consultations and increasing care access in remote areas. This ecosystem includes the telemedicine platform, the telemedicine service using providers, and firms developing software and devices related to telemedicine. Interoperability and secure data exchange from EHRs with telehealth systems are key to its success. Data privacy, regulatory standards, and reimbursement models significantly influence telemedicine effectiveness and growth. Effective collaboration among healthcare providers, technology developers, and regulators helps overcome the challenges of adoption and ethics, allowing telemedicine solutions to be widely accepted.

AI in Telehealth & Telemedicine Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

AI in Telehealth & Telemedicine Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

AI in telehealth & telemedicine market , By Application

The AI in telehealth market is segmented into primary care, specialty care, teleICU, and others, with primary care holding the largest share. Remote primary care enhances convenience, reduces the need for in-person visits, overcomes geographic barriers, and tackles shortages by allowing at-home healthcare. These advances manage chronic illnesses with prompt interventions and monitoring. Many companies, like K Health and Andor Health, offer telehealth platforms for primary care. In January 2023, Teladoc launched a comprehensive whole-person care app that combines primary care, mental health, and chronic disease management. CVS offers virtual primary care services, including 24/7 on-demand care and scheduled mental health support.

AI in telehealth & telemedicine market , By End User

End users include healthcare providers, payers, patients, pharma & biotech, medTech, and others. The patient segment is expected to grow the fastest due to increased demand for remote healthcare, particularly for chronic disease management, and the rising use of smartphones and wearable devices. Advances in wearable tech have boosted telemedicine, especially in remote monitoring and personalized care. For elderly patients, telehealth offers a convenient alternative to in-person visits, reducing travel and enabling home-based care. AI technologies, such as chatbots, virtual consultations, and remote monitoring, help patients manage their health proactively, increasing adoption across all ages and regions. In August 2024, Pfizer launched ‘PfizerForAll’ for appointment booking via telehealth, while US Medicare focuses on connecting patients to remote specialists and integrating telehealth into care.

AI in telehealth & telemedicine market , By Function

The remote patient monitoring (RPM) segment is projected to be the fastest-growing part of AI in telehealth, driven by the rise in chronic diseases like diabetes, hypertension, and CVDs that require constant management. RPM systems continuously track patient health data, reducing hospital visits and improving outcomes. Healthcare facilities, such as the Mayo Clinic (US), use RPM to reduce readmissions. In January 2025, Taiwan's ITRI introduced AI-based RPM devices developed with StreamTeck to monitor vitals like body temperature, heart rate, and blood pressure.

REGION

The Asia Pacific region is expected to be the fastest-growing region in the AI in telehealth and telemedicine market in 2024.

The AI in telehealth market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, the Asia Pacific became the fastest-growing market, driven by rapid advancements in digital health, increased government spending on telemedicine infrastructure, and rising smartphone and internet usage. Countries such as China, India, Japan, and Australia are actively adopting AI-powered telehealth solutions to enhance healthcare access and address doctor shortages. For example, in March 2024, India's Ministry of Health worked with NITI Aayog and various AI startups to introduce smart teleconsultation systems into rural health programs. Likewise, Ping An Good Doctor (China) and Doctor Anywhere (Singapore) expanded their AI-based virtual care platforms to boost patient engagement and enable remote diagnostics. These efforts, along with supportive regulations and growing public-private partnerships, are likely to speed up AI adoption and drive market growth across the Asia Pacific.

AI in Telehealth & Telemedicine Market Region

AI in Telehealth & Telemedicine Market: COMPANY EVALUATION MATRIX

Philips (Star) leads with a strong market share and an extensive product footprint, driven by its comprehensive AI-powered telehealth solutions, advanced remote diagnostic tools, and robust interoperability capabilities that are widely adopted across hospitals, clinics, and virtual care networks. Walgreens (Emerging Leader) is gaining visibility with its scalable AI-enabled telehealth platforms and virtual care services, strengthening its position through innovation, ease of integration, and targeted offerings for retail health clinics and community-based healthcare providers. While Philips dominates through scale and a diverse portfolio, Walgreens shows significant potential to move toward the leaders' quadrant as demand for interoperable, cloud-enabled, and AI-driven telehealth solutions continues to grow.

AI in Telehealth & Telemedicine Market Evaluation Matrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 4.22 Billion
Market Forecast in 2030 (Value) USD 27.14 Billion
Growth Rate CAGR of 36.4% from 2025-2030
Years Considered 2022-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Component:
    • Hardware
    • Software (by Modality
    • Integration Type
    • Deployment)
    • Services
  • By Application:
    • Primary Care Applications
    • Specialty Care Applications
    • TeleICU
    • Other Applications
  • By Function:
    • Virtual Care Consultations
    • Chatbots & Virtual Assistants
    • Remote Patient Monitoring
    • Virtual Nursing Care Platforms
    • Clinical Documentation
    • Administrative Workflow
    • Analytics & Reporting
    • Patient Engagement
    • Other Functions
  • By End User:
    • Healthcare Providers
    • Healthcare Payers
    • Patients
    • Pharma & Biotech Companies
    • MedTech Companies
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: AI in Telehealth & Telemedicine Market REPORT CONTENT GUIDE

AI in Telehealth & Telemedicine Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Client requested insights on the AI in Telehealth and Telemedicine Market in Middle East, focusing on growth drivers, regional trends, and market dynamics. Provided a detailed analysis highlighting AI-driven virtual care expansion, government-backed digital health initiatives, and integration of AI triage and diagnostic tools improving healthcare access and efficiency across Middle East (GCC Countries). Included custom growth driver, regional adoption examples (e.g., UAE’s Telehealth Guidelines, Saudi Arabia’s National eHealth Strategy), and strategic insights on AI’s role in improving healthcare accessibility and clinical efficiency.

RECENT DEVELOPMENTS

  • October 2024 : Zoom Communications Inc. (US) partnered with Suki AI, Inc. (US), a developer of AI-powered healthcare voice tools, to integrate advanced AI features into their telehealth services. Suki's AI engine, the Suki Platform, enables clinical documentation capabilities for in-person and virtual telehealth visits conducted through Zoom; this collaboration marks a significant step in leveraging AI to improve healthcare delivery
  • May 2024 : Baptist Health (US) and Caregility (US) partnered to improve patient care across the Arkansas-based healthcare organization. Baptist Health has doubled its inpatient telehealth services by increasing the use of Caregility’s intelligent telehealth devices to over 700 bedsides.
  • September 2024 : Oracle(US) and AvaSure (US) collaborated to develop an AI-powered virtual concierge solution for hospitals. Built on AvaSure's Intelligent Virtual Care Platform, OCI's AI capabilities, and NVIDIA's advanced computing infrastructure, the solution enhances patient care and streamlines workflows, delivering seamless smart room experiences across departments.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
35
2
RESEARCH METHODOLOGY
 
 
 
41
3
EXECUTIVE SUMMARY
 
 
 
55
4
PREMIUM INSIGHTS
 
 
 
60
5
MARKET OVERVIEW
Digital health surge driven by AI, virtual solutions, and regulatory support amidst skilled worker shortages.
 
 
 
64
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
INCREASING ADOPTION OF VIRTUAL ASSISTANT CHATBOTS
 
 
 
 
5.2.1.2
RISING POPULARITY OF E-PRESCRIPTIONS
 
 
 
 
5.2.1.3
GROWING ADOPTION OF EHRS IN HEALTHCARE SETTINGS
 
 
 
 
5.2.1.4
ADVANCEMENTS IN DIGITAL HEALTH TECHNOLOGIES
 
 
 
 
5.2.1.5
SHORTAGE OF SKILLED HEALTHCARE PROFESSIONALS
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
REGULATORY VARIATIONS ACROSS REGIONS
 
 
 
 
5.2.2.2
LACK OF ADVANCED TELEMEDICINE INFRASTRUCTURE IN EMERGING ECONOMIES
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
GROWING POPULARITY OF VIRTUAL HEALTHCARE SOLUTIONS
 
 
 
 
5.2.3.2
EMERGENCE OF AI AND ML
 
 
 
 
5.2.3.3
FAVORABLE GOVERNMENT INITIATIVES AND REIMBURSEMENT POLICIES
 
 
 
 
5.2.3.4
RISING FOCUS ON HOME HEALTHCARE
 
 
 
 
5.2.3.5
EXPANSION OF REMOTE PATIENT MONITORING MARKETS
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
INCREASING DATA BREACHES AND MEDICAL IDENTITY THEFT CASES
 
 
 
 
5.2.4.2
COMPLEXITIES OF BIG DATA IN HEALTHCARE
 
 
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
 
 
 
 
5.4
INDUSTRY TRENDS
 
 
 
 
 
5.4.1
GEN AI FOR MEDICAL DOCUMENTATION
 
 
 
 
5.4.2
INNOVATIONS IN REMOTE PATIENT MONITORING DEVICES
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.5.1
ROLE IN ECOSYSTEM
 
 
 
5.6
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.7
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.7.1
KEY TECHNOLOGIES
 
 
 
 
 
5.7.1.1
VIDEO CONFERENCING AND REAL-TIME COMMUNICATION PLATFORMS
 
 
 
 
5.7.1.2
VIRTUAL ASSISTANTS AND CHATBOTS
 
 
 
 
5.7.1.3
VOICE RECOGNITION AND NATURAL LANGUAGE PROCESSING
 
 
 
 
5.7.1.4
EHR INTEGRATION
 
 
 
 
5.7.1.5
REMOTE PATIENT MONITORING SYSTEMS
 
 
 
5.7.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.7.2.1
CLOUD COMPUTING
 
 
 
 
5.7.2.2
MHEALTH APPLICATIONS
 
 
 
 
5.7.2.3
WEARABLE DEVICES, SENSORS, AND IOT
 
 
 
5.7.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.7.3.1
DIGITAL THERAPEUTICS
 
 
 
 
5.7.3.2
BLOCKCHAIN TECHNOLOGIES
 
 
 
 
5.7.3.3
AUGMENTED REALITY AND VIRTUAL REALITY
 
 
5.8
TARIFF & REGULATORY ANALYSIS
 
 
 
 
 
5.8.1
TARIFF DATA ANALYSIS
 
 
 
 
 
5.8.1.1
AVERAGE TARIFF FOR HS CODE 9018
 
 
 
 
5.8.1.2
AVERAGE TARIFF FOR HS CODE 9021
 
 
 
 
5.8.1.3
AVERAGE TARIFF FOR HS CODE 9022
 
 
 
5.8.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
5.8.3
REGULATORY STANDARDS
 
 
 
 
5.8.4
REGULATORY REQUIREMENTS
 
 
 
5.9
TRADE ANALYSIS
 
 
 
 
 
 
5.9.1
TRADE ANALYSIS FOR HSN CODE 90189099, 2019–2023
 
 
 
 
 
5.9.1.1
TOP 10 IMPORTERS FOR HSN CODE 90189099
 
 
 
 
5.9.1.2
TOP 10 EXPORTERS FOR HSN CODE 90189099
 
 
 
5.9.2
TRADE ANALYSIS FOR HSN CODE 9021, 2019–2023
 
 
 
 
 
5.9.2.1
TOP 10 IMPORTERS FOR HSN CODE 9021
 
 
 
 
5.9.2.2
TOP 10 EXPORTERS FOR HSN CODE 9021
 
 
 
5.9.3
TRADE ANALYSIS FOR HSN CODE 9022, 2019–2023
 
 
 
 
 
5.9.3.1
TOP 10 IMPORTERS FOR HSN CODE 9022
 
 
 
 
5.9.3.2
TOP 10 EXPORTERS FOR HSN CODE 9022
 
 
5.10
PRICING ANALYSIS
 
 
 
 
 
 
5.10.1
INDICATIVE PRICE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY COMPONENT, 2023
 
 
 
 
5.10.2
AVERAGE PRICING TREND OF AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2022–2024
 
 
 
 
5.10.3
PRICING MODELS
 
 
 
5.11
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.11.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
5.11.2
THREAT OF NEW ENTRANTS
 
 
 
 
5.11.3
THREAT OF SUBSTITUTES
 
 
 
 
5.11.4
BARGAINING POWER OF BUYERS
 
 
 
 
5.11.5
BARGAINING POWER OF SUPPLIERS
 
 
 
5.12
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
5.12.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.12.2
KEY BUYING CRITERIA
 
 
 
5.13
PATENT ANALYSIS
 
 
 
 
 
 
5.13.1
PATENT PUBLICATION TRENDS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
5.13.2
INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS
 
 
 
5.14
UNMET NEEDS & END-USER EXPECTATIONS
 
 
 
 
 
5.14.1
UNMET NEEDS
 
 
 
 
5.14.2
END-USER EXPECTATIONS
 
 
 
5.15
KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
5.16
CASE STUDY ANALYSIS
 
 
 
 
 
5.16.1
TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH CAREGILITY VIRTUAL NURSING SOLUTION
 
 
 
 
5.16.2
TELADOC HEALTH TO PROVIDE MEDICARE ADVANTAGE PLAN FOR CLOSING GAPS AND BOOSTING QUALITY RATINGS
 
 
 
 
5.16.3
LMH HEALTH TO REDUCE NURSE WORKLOAD WITH VIRTUAL NURSING
 
 
 
5.17
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
5.18
BUSINESS MODEL ANALYSIS
 
 
 
 
 
5.18.1
DIRECT-TO-PATIENT (D2P) MODELS
 
 
 
 
5.18.2
BUSINESS-TO-BUSINESS (B2B) MODELS
 
 
 
 
5.18.3
EMPLOYER-SPONSORED MODELS
 
 
 
 
5.18.4
SUBSCRIPTION-BASED MODELS
 
 
 
 
5.18.5
HYBRID TELEMEDICINE MODELS
 
 
 
 
5.18.6
PLATFORM-AS-A-SERVICE (PAAS) MODELS
 
 
 
 
5.18.7
VALUE-BASED CARE MODELS
 
 
 
5.19
REIMBURSEMENT SCENARIO ANALYSIS
 
 
 
6
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 22 Data Tables
 
 
 
116
 
6.1
INTRODUCTION
 
 
 
 
6.2
HARDWARE
 
 
 
 
 
6.2.1
HIGH DEMAND FOR REMOTE PATIENT MONITORING DEVICES TO SPUR MARKET GROWTH
 
 
 
6.3
SOFTWARE
 
 
 
 
 
6.3.1
AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY
 
 
 
 
 
6.3.1.1
EHR-CENTRIC SOFTWARE
 
 
 
 
6.3.1.2
NON-EHR-CENTRIC SOFTWARE
 
 
 
6.3.2
AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE
 
 
 
 
 
6.3.2.1
INTEGRATED SOFTWARE
 
 
 
 
6.3.2.2
STANDALONE SOFTWARE
 
 
 
6.3.3
AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT
 
 
 
 
 
6.3.3.1
ON-PREMISES DEPLOYMENT
 
 
 
 
6.3.3.2
CLOUD-BASED DEPLOYMENT
 
 
6.4
SERVICES
 
 
 
 
 
6.4.1
TELEHEALTH SERVICES TO REDUCE IN-PERSON CLINIC VISITS AND ENSURE BETTER TREATMENT ACCESSIBILITY FOR REMOTE AREAS
 
 
7
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 16 Data Tables
 
 
 
130
 
7.1
INTRODUCTION
 
 
 
 
7.2
VIRTUAL CARE CONSULTATION
 
 
 
 
 
7.2.1
AI-BASED VIRTUAL CARE PLANS TO AUTOMATE DOCUMENTATION AND OFFER BETTER CLINICAL DECISION SUPPORT
 
 
 
7.3
CHATBOTS & VIRTUAL ASSISTANTS
 
 
 
 
 
7.3.1
CHATBOTS & VIRTUAL ASSISTANTS TO ENHANCE PATIENT ENGAGEMENT AND PROVIDE REAL-TIME HEALTH SUPPORT
 
 
 
7.4
REMOTE PATIENT MONITORING
 
 
 
 
 
7.4.1
EFFECTIVE REAL-TIME DISEASE MONITORING WITHOUT IN-PATIENT VISITS TO DRIVE MARKET
 
 
 
7.5
VIRTUAL NURSING CARE PLATFORMS
 
 
 
 
 
7.5.1
VIRTUAL NURSING PLATFORMS TO ELIMINATE NURSING SHORTAGES, REDUCE BURNOUT, AND PROVIDE HIGH-QUALITY CARE
 
 
 
7.6
CLINICAL DOCUMENTATION
 
 
 
 
 
7.6.1
NEED FOR ACCURATE AND COMPLIANT MEDICAL RECORDS FOR VIRTUAL CONSULTATIONS TO AUGMENT MARKET GROWTH
 
 
 
7.7
ADMINISTRATIVE WORKFLOW
 
 
 
 
 
7.7.1
EFFECTIVE RESOURCE MANAGEMENT AND OPERATIONAL EFFICIENCY TO AID MARKET GROWTH
 
 
 
7.8
ANALYTICS & REPORTING
 
 
 
 
 
7.8.1
ADVANCED ANALYTICS & REPORTING TOOLS TO FOSTER BETTER CARE COORDINATION AND PROVIDE PERSONALIZED TREATMENTS
 
 
 
7.9
PATIENT ENGAGEMENT
 
 
 
 
 
7.9.1
BETTER PATIENT ENGAGEMENT TO ADVANCE HEALTHCARE DELIVERY AND PROMOTE BETTER ADHERENCE TO TREATMENT PLANS
 
 
 
7.10
OTHER FUNCTIONS
 
 
 
8
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 18 Data Tables
 
 
 
141
 
8.1
INTRODUCTION
 
 
 
 
8.2
PRIMARY CARE APPLICATIONS
 
 
 
 
 
8.2.1
TECHNOLOGICAL ADVANCEMENTS AND DEMAND FOR PERSONALIZED HEALTHCARE DELIVERY TO PROPEL MARKET GROWTH
 
 
 
8.3
SPECIALTY CARE APPLICATIONS
 
 
 
 
 
8.3.1
TELERADIOLOGY
 
 
 
 
 
8.3.1.1
REDUCED TURNAROUND TIME FOR IMAGING REPORTS AND BETTER ACCESS TO RADIOLOGISTS IN REMOTE AREAS TO SUPPORT MARKET GROWTH
 
 
 
8.3.2
TELECARDIOLOGY
 
 
 
 
 
8.3.2.1
REAL-TIME ECG INTERPRETATIONS AND REMOTE CARDIAC CARE FOR CHRONIC PATIENTS TO AUGMENT MARKET GROWTH
 
 
 
8.3.3
TELENEUROLOGY
 
 
 
 
 
8.3.3.1
GROWING FOCUS ON ADVANCED NEUROLOGICAL CARE WITHOUT IN-PERSON VISITS TO AID MARKET GROWTH
 
 
 
8.3.4
DIABETES
 
 
 
 
 
8.3.4.1
RISING PREVALENCE OF DIABETES TO DRIVE MARKET
 
 
 
8.3.5
RESPIRATORY DISORDERS
 
 
 
 
 
8.3.5.1
INCREASING INCIDENCE OF RESPIRATORY DISEASES AMONG GERIATRIC POPULATION TO PROPEL MARKET GROWTH
 
 
 
8.3.6
HYPERTENSION
 
 
 
 
 
8.3.6.1
NEED FOR CONSTANT MONITORING AND HIGH PREVALENCE OF HYPERTENSION TO BOOST MARKET GROWTH
 
 
 
8.3.7
TELEDERMATOLOGY
 
 
 
 
 
8.3.7.1
INCREASED OCCURRENCE OF SKIN CANCER TO FUEL MARKET GROWTH
 
 
 
8.3.8
TELEPSYCHIATRY
 
 
 
 
 
8.3.8.1
SHORTAGE OF MENTAL HEALTH PRACTITIONERS IN RURAL AREAS TO FUEL UPTAKE
 
 
 
8.3.9
OTHER SPECIALTY CARE APPLICATIONS
 
 
 
8.4
TELEICU
 
 
 
 
 
8.4.1
INCREASE IN EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF ER SPECIALISTS TO PROPEL MARKET GROWTH
 
 
 
8.5
OTHER APPLICATIONS
 
 
 
9
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 13 Data Tables
 
 
 
154
 
9.1
INTRODUCTION
 
 
 
 
9.2
HEALTHCARE PROVIDERS
 
 
 
 
 
9.2.1
HOSPITALS
 
 
 
 
 
9.2.1.1
GROWING INCIDENCE OF CHRONIC DISEASES AND INCREASING DEMAND FOR HIGH-QUALITY CARE TO AID MARKET GROWTH
 
 
 
9.2.2
AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
 
 
 
 
 
9.2.2.1
COST-EFFECTIVENESS AND REDUCED PATIENT DOWNTIME TO AUGMENT MARKET GROWTH
 
 
 
9.2.3
LONG-TERM CARE & ASSISTED LIVING FACILITIES
 
 
 
 
 
9.2.3.1
NEED FOR PROLONGED TREATMENT FOR CHRONIC DISEASES TO SUPPORT MARKET GROWTH
 
 
 
9.2.4
HOME HEALTHCARE
 
 
 
 
 
9.2.4.1
DEMAND FOR COST-EFFECTIVE SOLUTIONS AND LOW HOSPITAL READMISSIONS TO PROPEL SEGMENT GROWTH
 
 
 
9.2.5
OTHER HEALTHCARE PROVIDERS
 
 
 
9.3
HEALTHCARE PAYERS
 
 
 
 
 
9.3.1
HEALTHCARE PAYERS TO REDUCE OVERHEAD COSTS, MINIMIZE PAPER TRAILS, AND IMPROVE MEMBER SERVICES
 
 
 
9.4
PATIENTS
 
 
 
 
 
9.4.1
EMERGENCE OF ADVANCED WEARABLE DEVICES AND USE OF AI IN PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH
 
 
 
9.5
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
9.5.1
NEED FOR STREAMLINED DRUG DEVELOPMENT PROCESSES AND ENHANCED CLINICAL TRIAL PARTICIPATION TO DRIVE MARKET
 
 
 
9.6
MEDTECH COMPANIES
 
 
 
 
 
9.6.1
MEDTECH COMPANIES TO IMPROVE DIAGNOSTIC ACCURACY AND FACILITATE PERSONALIZED TREATMENT PLANS
 
 
 
9.7
OTHER END USERS
 
 
 
10
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 12 Countries | 204 Data Tables.
 
 
 
167
 
10.1
INTRODUCTION
 
 
 
 
10.2
NORTH AMERICA
 
 
 
 
 
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
10.2.2
US
 
 
 
 
 
10.2.2.1
US TO DOMINATE NORTH AMERICAN MARKET DURING FORECAST PERIOD
 
 
 
10.2.3
CANADA
 
 
 
 
 
10.2.3.1
GOVERNMENT INITIATIVES ON DIGITAL HEALTH INTEGRATION TO DRIVE ADOPTION OF TELEHEALTH AND MHEALTH APPLICATIONS
 
 
10.3
EUROPE
 
 
 
 
 
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
10.3.2
GERMANY
 
 
 
 
 
10.3.2.1
FAVORABLE GOVERNMENT INITIATIVES TO SUPPORT MARKET GROWTH
 
 
 
10.3.3
UK
 
 
 
 
 
10.3.3.1
GROWING RELIANCE ON DIGITAL HEALTHCARE PLATFORMS AND INCREASING INVESTMENTS IN REMOTE MENTAL HEALTH SERVICES TO DRIVE MARKET
 
 
 
10.3.4
FRANCE
 
 
 
 
 
10.3.4.1
FAVORABLE REIMBURSEMENT FOR TELEMEDICINE SOLUTIONS TO SPUR MARKET GROWTH
 
 
 
10.3.5
ITALY
 
 
 
 
 
10.3.5.1
STRATEGIC GOVERNMENT REGULATIONS AND HIGH INVESTMENTS IN HEALTHCARE DIGITALIZATION TO AUGMENT MARKET GROWTH
 
 
 
10.3.6
SPAIN
 
 
 
 
 
10.3.6.1
RAPID EXPANSION OF EHEALTH SECTOR AND INCREASED ADOPTION OF WEARABLE TECHNOLOGIES TO FAVOR MARKET GROWTH
 
 
 
10.3.7
REST OF EUROPE
 
 
 
10.4
ASIA PACIFIC
 
 
 
 
 
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
10.4.2
CHINA
 
 
 
 
 
10.4.2.1
INCREASING PRIVATE SECTOR INVESTMENTS IN DIGITAL INFRASTRUCTURE TO BOOST MARKET GROWTH
 
 
 
10.4.3
JAPAN
 
 
 
 
 
10.4.3.1
HIGH GERIATRIC POPULATION AND STRONG TECHNOLOGICAL INFRASTRUCTURE TO PROPEL MARKET GROWTH
 
 
 
10.4.4
INDIA
 
 
 
 
 
10.4.4.1
INCREASED GOVERNMENT FOCUS ON DIGITAL TRANSFORMATION IN RURAL AREAS TO AID MARKET GROWTH
 
 
 
10.4.5
REST OF ASIA PACIFIC
 
 
 
10.5
LATIN AMERICA
 
 
 
 
 
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
10.5.2
BRAZIL
 
 
 
 
 
10.5.2.1
INCREASING ADOPTION OF DIGITAL HEALTH SOLUTIONS IN PUBLIC AND PRIVATE SYSTEMS TO AID MARKET GROWTH
 
 
 
10.5.3
MEXICO
 
 
 
 
 
10.5.3.1
FAVORABLE REGULATORY SCENARIO TO FUEL MARKET GROWTH
 
 
 
10.5.4
REST OF LATIN AMERICA
 
 
 
10.6
MIDDLE EAST & AFRICA
 
 
 
 
 
10.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
10.6.2
GCC COUNTRIES
 
 
 
 
 
10.6.2.1
SHORTAGE OF SKILLED HEALTHCARE WORKFORCE TO SUPPORT MARKET GROWTH
 
 
 
10.6.3
REST OF MIDDLE EAST & AFRICA
 
 
11
COMPETITIVE LANDSCAPE
Discover AI telehealth market leaders and emerging startups reshaping competitive dynamics.
 
 
 
273
 
11.1
INTRODUCTION
 
 
 
 
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
11.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET
 
 
 
11.3
REVENUE ANALYSIS, 2020–2024
 
 
 
 
 
11.4
MARKET SHARE ANALYSIS, 2023
 
 
 
 
 
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
 
 
 
 
 
 
11.5.1
STARS
 
 
 
 
11.5.2
EMERGING LEADERS
 
 
 
 
11.5.3
PERVASIVE PLAYERS
 
 
 
 
11.5.4
PARTICIPANTS
 
 
 
 
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
 
 
 
 
 
11.5.5.1
COMPANY FOOTPRINT
 
 
 
 
11.5.5.2
REGION FOOTPRINT
 
 
 
 
11.5.5.3
FUNCTION FOOTPRINT
 
 
 
 
11.5.5.4
APPLICATION FOOTPRINT
 
 
 
 
11.5.5.5
COMPONENT FOOTPRINT
 
 
 
 
11.5.5.6
END-USER FOOTPRINT
 
 
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
 
 
 
 
 
 
11.6.1
PROGRESSIVE COMPANIES
 
 
 
 
11.6.2
RESPONSIVE COMPANIES
 
 
 
 
11.6.3
DYNAMIC COMPANIES
 
 
 
 
11.6.4
STARTING BLOCKS
 
 
 
 
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
 
 
 
 
 
11.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
11.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION
 
 
11.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
11.7.1
FINANCIAL METRICS
 
 
 
 
11.7.2
COMPANY VALUATION
 
 
 
11.8
BRAND/SOFTWARE COMPARISON
 
 
 
 
11.9
COMPETITIVE SCENARIO
 
 
 
 
 
11.9.1
PRODUCT LAUNCHES & APPROVALS
 
 
 
 
11.9.2
DEALS
 
 
12
COMPANY PROFILE
 
 
 
294
 
12.1
KEY PLAYERS
 
 
 
 
 
12.1.1
MEDTRONIC
 
 
 
 
 
12.1.1.1
BUSINESS OVERVIEW
 
 
 
 
12.1.1.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.1.4
MNM VIEW
 
 
 
12.1.2
TELADOC HEALTH, INC.
 
 
 
 
 
12.1.2.1
BUSINESS OVERVIEW
 
 
 
 
12.1.2.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.2.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.2.4
MNM VIEW
 
 
 
12.1.3
KONINKLIJKE PHILIPS N.V.
 
 
 
 
 
12.1.3.1
BUSINESS OVERVIEW
 
 
 
 
12.1.3.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.3.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.3.4
MNM VIEW
 
 
 
12.1.4
CISCO SYSTEMS, INC.
 
 
 
 
 
12.1.4.1
BUSINESS OVERVIEW
 
 
 
 
12.1.4.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.4.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.4.4
MNM VIEW
 
 
 
12.1.5
GE HEALTHCARE
 
 
 
 
 
12.1.5.1
BUSINESS OVERVIEW
 
 
 
 
12.1.5.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.5.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.5.4
MNM VIEW
 
 
 
12.1.6
EPIC SYSTEMS CORPORATION
 
 
 
 
 
12.1.6.1
BUSINESS OVERVIEW
 
 
 
 
12.1.6.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.6.3
RECENT DEVELOPMENTS
 
 
 
12.1.7
ORACLE
 
 
 
 
 
12.1.7.1
BUSINESS OVERVIEW
 
 
 
 
12.1.7.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.7.3
RECENT DEVELOPMENTS
 
 
 
12.1.8
DOXIMITY, INC.
 
 
 
 
 
12.1.8.1
BUSINESS OVERVIEW
 
 
 
 
12.1.8.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.8.3
RECENT DEVELOPMENTS
 
 
 
12.1.9
INCLUDED HEALTH, INC.
 
 
 
 
 
12.1.9.1
BUSINESS OVERVIEW
 
 
 
 
12.1.9.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.9.3
RECENT DEVELOPMENTS
 
 
 
12.1.10
ZOOM COMMUNICATIONS, INC.
 
 
 
 
 
12.1.10.1
BUSINESS OVERVIEW
 
 
 
 
12.1.10.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.10.3
RECENT DEVELOPMENTS
 
 
 
12.1.11
AMERICAN WELL
 
 
 
 
 
12.1.11.1
BUSINESS OVERVIEW
 
 
 
 
12.1.11.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.11.3
RECENT DEVELOPMENTS
 
 
 
12.1.12
SIEMENS HEALTHINEERS AG
 
 
 
 
 
12.1.12.1
BUSINESS OVERVIEW
 
 
 
 
12.1.12.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.12.3
RECENT DEVELOPMENTS
 
 
 
12.1.13
AMC HEALTH
 
 
 
 
 
12.1.13.1
BUSINESS OVERVIEW
 
 
 
 
12.1.13.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.13.3
RECENT DEVELOPMENTS
 
 
 
12.1.14
TELESPECIALISTS
 
 
 
 
 
12.1.14.1
BUSINESS OVERVIEW
 
 
 
 
12.1.14.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.14.3
RECENT DEVELOPMENTS
 
 
 
12.1.15
WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)
 
 
 
 
 
12.1.15.1
BUSINESS OVERVIEW
 
 
 
 
12.1.15.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.15.3
RECENT DEVELOPMENTS
 
 
 
12.1.16
CAREGILITY
 
 
 
 
 
12.1.16.1
BUSINESS OVERVIEW
 
 
 
 
12.1.16.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.16.3
RECENT DEVELOPMENTS
 
 
 
12.1.17
CVS HEALTH
 
 
 
 
 
12.1.17.1
BUSINESS OVERVIEW
 
 
 
 
12.1.17.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.17.3
RECENT DEVELOPMENTS
 
 
 
12.1.18
ALIVECOR, INC.
 
 
 
 
 
12.1.18.1
BUSINESS OVERVIEW
 
 
 
 
12.1.18.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.18.3
RECENT DEVELOPMENTS
 
 
 
12.1.19
ELATION
 
 
 
 
 
12.1.19.1
BUSINESS OVERVIEW
 
 
 
 
12.1.19.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.19.3
RECENT DEVELOPMENTS
 
 
 
12.1.20
HEALTHTAP, INC.
 
 
 
 
 
12.1.20.1
BUSINESS OVERVIEW
 
 
 
 
12.1.20.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
12.1.20.3
RECENT DEVELOPMENTS
 
 
12.2
OTHER PLAYERS
 
 
 
 
 
12.2.1
CURAI HEALTH
 
 
 
 
12.2.2
ANDOR HEALTH
 
 
 
 
12.2.3
K HEALTH
 
 
 
 
12.2.4
TRANSCARENT
 
 
 
 
12.2.5
BIOINTELLISENSE, INC.
 
 
13
APPENDIX
 
 
 
375
 
13.1
DISCUSSION GUIDE
 
 
 
 
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
13.3
CUSTOMIZATION OPTIONS
 
 
 
 
13.4
RELATED REPORTS
 
 
 
 
13.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
AI IN TELEHEALTH & TELEMEDICINE MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
TABLE 2
AI IN TELEHEALTH & TELEMEDICINE MARKET: STUDY ASSUMPTIONS
 
 
 
 
TABLE 3
AI IN TELEHEALTH & TELEMEDICINE MARKET: RISK ANALYSIS
 
 
 
 
TABLE 4
MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
TABLE 5
RECENT DEVELOPMENTS FOR REMOTE PATIENT MONITORING SYSTEMS
 
 
 
 
TABLE 6
TOP 30 HEALTHCARE DATA BREACHES IN US, 2011−2024
 
 
 
 
TABLE 7
AI IN TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM
 
 
 
 
TABLE 8
AVERAGE TARIFF FOR HS CODE 9018 IN 2023
 
 
 
 
TABLE 9
AVERAGE TARIFF FOR HS CODE 9021 IN 2023
 
 
 
 
TABLE 10
AVERAGE TARIFF FOR HS CODE 9022 IN 2023
 
 
 
 
TABLE 11
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 13
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 14
AI IN TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS
 
 
 
 
TABLE 15
REGULATORY REQUIREMENTS IN NORTH AMERICA
 
 
 
 
TABLE 16
REGULATORY REQUIREMENTS IN EUROPE
 
 
 
 
TABLE 17
REGULATORY REQUIREMENTS IN ASIA PACIFIC
 
 
 
 
TABLE 18
REGULATORY REQUIREMENTS IN LATIN AMERICA
 
 
 
 
TABLE 19
REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA
 
 
 
 
TABLE 20
TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 21
TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 22
TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 23
TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 24
TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 25
TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 26
COST RANGE INVOLVED IN AI-BASED TELEHEALTH & TELEMEDICINE DEVICES (USD)
 
 
 
 
TABLE 27
INDICATIVE PRICE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY COMPONENT, 2023
 
 
 
 
TABLE 28
AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS
 
 
 
 
TABLE 29
AVERAGE PRICING TREND OF AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2022–2024 (USD)
 
 
 
 
TABLE 30
AI IN TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES
 
 
 
 
TABLE 31
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS
 
 
 
 
TABLE 32
KEY BUYING CRITERIA FOR TOP THREE COMPONENTS
 
 
 
 
TABLE 33
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
TABLE 34
AI IN TELEHEALTH & TELEMEDICINE MARKET: UNMET NEEDS
 
 
 
 
TABLE 35
AI IN TELEHEALTH & TELEMEDICINE MARKET: END-USER EXPECTATIONS
 
 
 
 
TABLE 36
AI IN TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
 
 
 
 
TABLE 37
CASE STUDY 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH CAREGILITY VIRTUAL NURSING SOLUTION
 
 
 
 
TABLE 38
CASE STUDY 2: TELADOC HEALTH TO PROVIDE MEDICARE ADVANTAGE PLAN FOR CLOSING GAPS AND BOOSTING QUALITY RATINGS
 
 
 
 
TABLE 39
CASE STUDY 3: LMH HEALTH TO REDUCE NURSE WORKLOAD WITH VIRTUAL NURSING
 
 
 
 
TABLE 40
AI IN TELEHEALTH & TELEMEDICINE MARKET: CPT CODES AND REIMBURSEMENT ANALYSIS
 
 
 
 
TABLE 41
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 42
MAJOR COMPANIES OFFERING HARDWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
TABLE 43
AI IN TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 44
AI IN TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION, 2022–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 45
MAJOR COMPANIES OFFERING SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
TABLE 46
AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 47
AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 48
MAJOR COMPANIES OFFERING EHR-CENTRIC SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
TABLE 49
EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 50
MAJOR COMPANIES OFFERING NON-EHR-CENTRIC SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
TABLE 51
NON-EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 52
AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 53
MAJOR COMPANIES OFFERING INTEGRATED SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
TABLE 54
INTEGRATED SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 55
MAJOR COMPANIES OFFERING STANDALONE SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
TABLE 56
STANDALONE SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 57
AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 58
ON-PREMISES DEPLOYMENT MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 59
MAJOR COMPANIES OFFERING CLOUD-BASED DEPLOYMENT FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
TABLE 60
CLOUD-BASED DEPLOYMENT MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 61
MAJOR COMPANIES OFFERING AI-BASED TELEHEALTH & TELEMEDICINE SERVICES
 
 
 
 
TABLE 62
AI IN TELEHEALTH & TELEMEDICINE SERVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 63
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 64
MAJOR COMPANIES OFFERING VIRTUAL CARE CONSULTATIONS
 
 
 
 
TABLE 65
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL CARE CONSULTATION, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 66
MAJOR COMPANIES OFFERING CHATBOTS & VIRTUAL ASSISTANTS
 
 
 
 
TABLE 67
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR CHATBOTS & VIRTUAL ASSISTANTS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 68
MAJOR COMPANIES OFFERING REMOTE PATIENT MONITORING
 
 
 
 
TABLE 69
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 70
MAJOR COMPANIES OFFERING VIRTUAL NURSING CARE
 
 
 
 
TABLE 71
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL NURSING CARE PLATFORMS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 72
MAJOR COMPANIES OFFERING CLINICAL DOCUMENTATION
 
 
 
 
TABLE 73
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL DOCUMENTATION, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 74
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE WORKFLOW, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 75
MAJOR COMPANIES OFFERING ANALYTICS & REPORTING
 
 
 
 
TABLE 76
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 77
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 78
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 79
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 80
MAJOR COMPANIES OFFERING PRIMARY CARE APPLICATIONS
 
 
 
 
TABLE 81
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 82
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 83
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 84
TELERADIOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 85
TELECARDIOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 86
TELENEUROLOGY MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 87
MAJOR COMPANIES OFFERING SOLUTIONS FOR DIABETES
 
 
 
 
TABLE 88
DIABETES MARKET, BY REGION 2022–2030 (USD MILLION)
 
 
 
 
TABLE 89
MAJOR COMPANIES OFFERING SOLUTIONS FOR RESPIRATORY DISORDERS
 
 
 
 
TABLE 90
RESPIRATORY DISORDERS MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 91
HYPERTENSION MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 92
TELEDERMATOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 93
TELEPSYCHIATRY MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 94
OTHER SPECIALTY CARE APPLICATIONS MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 95
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 96
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 97
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 98
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 99
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 100
HOSPITALS MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 101
AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 102
LONG-TERM CARE & ASSISTED LIVING FACILITIES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 103
HOME HEALTHCARE MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 104
OTHER HEALTHCARE PROVIDERS MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 105
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 106
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 107
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 108
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 109
AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 110
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 111
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 112
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 113
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 114
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 115
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 116
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 117
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 118
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 119
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 120
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 121
US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 122
US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 123
US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 124
US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 125
US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 126
US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 127
US: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 128
US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 129
US: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 130
CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 131
CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 132
CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 133
CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 134
CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 135
CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 136
CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 137
CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 138
CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 139
EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 140
EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 141
EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 142
EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 143
EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 144
EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 145
EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 146
EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 147
EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 148
EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 149
GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 150
GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 151
GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 152
GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 153
GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 154
GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 155
GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 156
GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 157
GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 158
UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 159
UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 160
UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 161
UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 162
UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 163
UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 164
UK: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 165
UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 166
UK: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 167
FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 168
FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 169
FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 170
FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 171
FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 172
FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 173
FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 174
FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 175
FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 176
ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 177
ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 178
ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 179
ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 180
ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 181
ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 182
ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 183
ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 184
ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 185
SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 186
SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 187
SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 188
SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 189
SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 190
SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 191
SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 192
SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 193
SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 194
REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 195
REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 196
REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 197
REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 198
REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 199
REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 200
REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 201
REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 202
REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 203
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 204
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 205
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 206
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 207
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 208
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 209
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 210
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 211
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 212
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 213
CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 214
CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 215
CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 216
CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 217
CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 218
CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 219
CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 220
CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 221
CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 222
JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 223
JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 224
JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 225
JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 226
JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 227
JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 228
JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 229
JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 230
JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 231
INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 232
INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 233
INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 234
INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 235
INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 236
INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 237
INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 238
INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 239
INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 240
REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 241
REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 242
REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 243
REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 244
REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 245
REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 246
REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 247
REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 248
REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 249
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 250
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 251
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 252
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 253
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 254
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 255
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 256
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 257
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 258
LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 259
BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 260
BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 261
BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 262
BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 263
BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 264
BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 265
BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 266
BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 267
BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 268
MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 269
MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 270
MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 271
MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 272
MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 273
MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 274
MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 275
MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 276
MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDER BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 277
REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 278
REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 279
REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 280
REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 281
REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 282
REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 283
REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 284
REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 285
REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 286
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 287
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 288
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 289
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 290
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 291
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 292
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 293
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 294
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 295
MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 296
GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 297
GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 298
GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 299
GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 300
GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 301
GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 302
GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 303
GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 304
GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 305
REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 306
REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 307
REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 308
REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 309
REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 310
REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 311
REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 312
REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 313
REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 314
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 315
AI IN TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 316
AI IN TELEHEALTH & TELEMEDICINE MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 317
AI IN TELEHEALTH & TELEMEDICINE MARKET: FUNCTION FOOTPRINT
 
 
 
 
TABLE 318
AI IN TELEHEALTH & TELEMEDICINE MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 319
AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPONENT FOOTPRINT
 
 
 
 
TABLE 320
AI IN TELEHEALTH & TELEMEDICINE MARKET: END-USER FOOTPRINT
 
 
 
 
TABLE 321
AI IN TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
 
 
 
 
TABLE 322
AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY REGION
 
 
 
 
TABLE 323
AI IN TELEHEALTH & TELEMEDICINE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 324
AI IN TELEHEALTH & TELEMEDICINE MARKET: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 325
MEDTRONIC: COMPANY OVERVIEW
 
 
 
 
TABLE 326
MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 327
MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 328
MEDTRONIC: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 329
TELADOC HEALTH, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 330
TELADOC HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 331
TELADOC HEALTH, INC.: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 332
TELADOC HEALTH, INC.: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 333
KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
 
 
 
 
TABLE 334
KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 335
KONINKLIJKE PHILIPS N.V.: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 336
KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 337
CISCO SYSTEMS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 338
CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 339
CISCO SYSTEMS, INC.: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 340
CISCO SYSTEMS, INC.: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 341
GE HEALTHCARE: COMPANY OVERVIEW
 
 
 
 
TABLE 342
GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 343
GE HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 344
GE HEALTHCARE: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 345
EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 346
EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 347
EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 348
EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 349
ORACLE: COMPANY OVERVIEW
 
 
 
 
TABLE 350
ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 351
ORACLE: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 352
ORACLE: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 353
DOXIMITY, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 354
DOXIMITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 355
DOXIMITY, INC.: PRODUCT UPGRADES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 356
DOXIMITY, INC.: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 357
DOXIMITY, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 358
INCLUDED HEALTH, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 359
INCLUDED HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 360
INCLUDED HEALTH, INC.: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 361
INCLUDED HEALTH, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 362
ZOOM COMMUNICATIONS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 363
ZOOM COMMUNICATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 364
ZOOM COMMUNICATIONS, INC.: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 365
AMERICAN WELL: COMPANY OVERVIEW
 
 
 
 
TABLE 366
AMERICAN WELL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 367
AMERICAN WELL: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 368
AMERICAN WELL: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 369
AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 370
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
 
 
 
 
TABLE 371
SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 372
SIEMENS HEALTHINEERS AG: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 373
AMC HEALTH: COMPANY OVERVIEW
 
 
 
 
TABLE 374
AMC HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 375
AMC HEALTH: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 376
TELESPECIALISTS: COMPANY OVERVIEW
 
 
 
 
TABLE 377
TELESPECIALISTS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 378
TELESPECIALISTS: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 379
TELESPECIALISTS: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 380
TELESPECIALISTS: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 381
WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY OVERVIEW
 
 
 
 
TABLE 382
WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 383
WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 384
WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): EXPANSIONS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 385
CAREGILITY: COMPANY OVERVIEW
 
 
 
 
TABLE 386
CAREGILITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 387
CAREGILITY: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 388
CAREGILITY: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 389
CAREGILITY: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 390
CVS HEALTH: COMPANY OVERVIEW
 
 
 
 
TABLE 391
CVS HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 392
CVS HEALTH: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 393
ALIVECOR, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 394
ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 395
ALIVECOR, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 396
ALIVECOR, INC.: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 397
ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 398
ELATION: COMPANY OVERVIEW
 
 
 
 
TABLE 399
ELATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 400
ELATION: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 401
HEALTHTAP, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 402
HEALTHTAP, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 403
HEALTHTAP, INC.: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 404
HEALTHTAP, INC.: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 405
CURAI HEALTH: COMPANY OVERVIEW
 
 
 
 
TABLE 406
ANDOR HEALTH: COMPANY OVERVIEW
 
 
 
 
TABLE 407
K HEALTH: COMPANY OVERVIEW
 
 
 
 
TABLE 408
TRANSACARENT: COMPANY OVERVIEW
 
 
 
 
TABLE 409
BIOINTELLISENSE, INC.: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
AI IN TELEHEALTH & TELEMEDICINE MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE
 
 
 
 
FIGURE 2
AI IN TELEHEALTH & TELEMEDICINE MARKET: YEARS CONSIDERED
 
 
 
 
FIGURE 3
AI IN TELEHEALTH & TELEMEDICINE MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 4
AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM SECONDARY SOURCES
 
 
 
 
FIGURE 5
AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY PRIMARY SOURCES
 
 
 
 
FIGURE 6
AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM PRIMARY SOURCES
 
 
 
 
FIGURE 7
AI IN TELEHEALTH & TELEMEDICINE MARKET: INSIGHTS FROM PRIMARIES
 
 
 
 
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 9
MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
 
 
 
 
FIGURE 10
AI IN TELEHEALTH & TELEMEDICINE MARKET: TOP-DOWN APPROACH
 
 
 
 
FIGURE 11
AI IN TELEHEALTH & TELEMEDICINE MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030)
 
 
 
 
FIGURE 12
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 13
AI IN TELEHEALTH & TELEMEDICINE MARKET: DATA TRIANGULATION
 
 
 
 
FIGURE 14
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 15
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 16
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 17
AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 18
AI IN TELEHEALTH & TELEMEDICINE MARKET: REGIONAL SNAPSHOT
 
 
 
 
FIGURE 19
TECHNOLOGICAL ADVANCEMENTS AND NEED TO REDUCE HEALTHCARE EXPENSES TO PROPEL MARKET GROWTH
 
 
 
 
FIGURE 20
US AND SOFTWARE SEGMENT DOMINATED NORTH AMERICAN MARKET IN 2023
 
 
 
 
FIGURE 21
CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030
 
 
 
 
FIGURE 22
EMERGING MARKETS TO GROW AT HIGHER RATES DURING STUDY PERIOD
 
 
 
 
FIGURE 23
AI IN TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 24
AMERICAN HOSPITAL ASSOCIATION (AHA) ANNUAL SURVEY ON EHR ADOPTION AMONG HOSPITALS AND OFFICE-BASED PHYSICIANS (2008–2021)
 
 
 
 
FIGURE 25
HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024
 
 
 
 
FIGURE 26
INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023
 
 
 
 
FIGURE 27
AI IN TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
 
 
 
 
FIGURE 28
AI IN TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 29
AI IN TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 30
AI IN TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 31
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS
 
 
 
 
FIGURE 32
KEY BUYING CRITERIA FOR TOP THREE COMPONENTS
 
 
 
 
FIGURE 33
GLOBAL PATENT PUBLICATION TRENDS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, 2015–2025
 
 
 
 
FIGURE 34
JURISDICTION & TOP APPLICANT ANALYSIS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
 
 
 
 
FIGURE 35
TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES (JANUARY 2015–MARCH 2025)
 
 
 
 
FIGURE 36
AI IN TELEHEALTH & TELEMEDICINE MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024
 
 
 
 
FIGURE 37
NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT
 
 
 
 
FIGURE 38
ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT
 
 
 
 
FIGURE 39
REVENUE ANALYSIS OF KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET, 2020–2024 (USD MILLION)
 
 
 
 
FIGURE 40
MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET (2023)
 
 
 
 
FIGURE 41
AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
 
 
 
 
FIGURE 42
AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 43
AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
 
 
 
 
FIGURE 44
EV/EBITDA OF KEY AI-BASED TELEHEALTH & TELEMEDICINE PLAYERS, 2024
 
 
 
 
FIGURE 45
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF AI-BASED TELEHEALTH & TELEMEDICINE PLAYERS, 2024
 
 
 
 
FIGURE 46
AI IN TELEHEALTH & TELEMEDICINE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 47
MEDTRONIC: COMPANY SNAPSHOT
 
 
 
 
FIGURE 48
TELADOC HEALTH, INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 49
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 50
CISCO SYSTEMS, INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 51
GE HEALTHCARE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 52
ORACLE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 53
DOXIMITY, INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 54
ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 55
AMERICAN WELL: COMPANY SNAPSHOT
 
 
 
 
FIGURE 56
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
 
 
 
 
FIGURE 57
WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY SNAPSHOT
 
 
 
 
FIGURE 58
CVS HEALTH: COMPANY SNAPSHOT
 
 
 
 

Methodology

The study involved significant activities to estimate the current size of the AI in telehealth & telemedicine market. Exhaustive secondary research was done to collect information on the market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in telehealth & telemedicine market.

Secondary Research

This research study used secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The companies offering AI-based telehealth & telemedicine solutions were determined at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

The secondary research process referred to various secondary sources to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in telehealth & telemedicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as CEOs, VPs, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in telehealth market.

After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI-based telemedicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

Breakdown Of Primary Participants

AI in Telehealth & Telemedicine Market

Note 1: Other designations include sales, marketing, and product managers.

Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in telehealth & telemedicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • In terms of value, the industry’s supply chain and market size have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
AI in Telehealth & Telemedicine Market

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size using the market size estimation processes explained above. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Telehealth:Telehealth represents a broad group of healthcare services, including care, education, and other services, made possible through various digital communication technologies; these services are facilitated by telecommunications equipment such as video conferencing, mobile applications, RPM devices, and wearable health technologies. Telehealth offers various services, including preventive care, chronic disease management, mental health support, and virtual consultations. The integration of AI in telehealth enhances remote care by enabling real-time monitoring, virtual assistants, diagnostics, personalized treatment, and predictive analytics.

Telemedicine: Telemedicine is a specific subset of telehealth focused exclusively on remote clinical services. It involves using electronic communications to diagnose, treat, and manage patients without requiring in-person visits. Telemedicine includes real-time video consultations, remote health data monitoring, and the store-and-forward method, where medical information is collected and sent to specialists for evaluation. NLP automates medical documentation and supports AI-powered virtual consultations, reducing administrative burdens on healthcare professionals.

Stakeholders

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Technology & AI Companies
  • Regulatory Authorities
  • Hospitals & Healthcare Providers
  • Patients & Patient Advocacy Groups
  • Clinical Trial Investigators & Site Coordinators
  • Data Management & Analytics Firms
  • Academic Institutions & Research Organizations
  • Investors & Venture Capital Firms
  • Clinical Trial Software Providers
  • Ethics Committees and Institutional Review Boards (IRBs)
  • Insurance Companies
  • Telehealth Software Providers
  • RPM Solutions
  • Healthcare IT Service Providers

Report Objectives

  • To define, describe, and forecast the AI in telehealth & telemedicine market based on component, function, application, end user, and region
  • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the market growth
  • To analyze opportunities for stakeholders by identifying the high-growth market segments
  • To forecast the size of the market segments with respect to the five main regions: North America, Europe, the Asia Pacific, the Middle East & Africa, and Latin America
  • To analyze subsegments of the market concerning individual growth trends, prospects, and contributions to the overall market
  • To profile the key players and comprehensively analyze their market sizes and core competencies.
  • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product approvals, product launches & updates, partnerships, expansions, and other recent developments in the global market.

 

Frequently Asked Questions (FAQ)

What are the major market players covered in the reports?

The key players in the AI in telehealth and telemedicine market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), and Teladoc Health, Inc. (US), among others.

Define AI in telehealth & telemedicine market.

Telehealth refers to a broad group of healthcare services, including care, education, and other services delivered through digital communication technologies such as video conferencing, mobile applications, remote patient monitoring devices, and wearable health technologies. The integration of AI in telehealth enhances remote care with real-time monitoring, virtual assistants, diagnostics, personalized treatment, and predictive analytics. Telemedicine is a subset of telehealth focused on remote clinical services. It uses electronic communications for diagnosis, treatment, and patient management without requiring in-person visits. Telemedicine includes real-time video consultations, remote health data monitoring, and store-and-forward methods. AI technologies such as natural language processing assist with medical documentation and enable AI-powered virtual consultations, helping reduce the administrative burden on healthcare professionals.

Which region is expected to have the largest market share in the AI in telehealth and telemedicine market?

North America is expected to hold the largest market share in the AI in telehealth and telemedicine market during the forecast period.

Which end-user segments have been included in the AI in telehealth and telemedicine market report?

The report includes end-user segments such as healthcare providers, hospitals, ambulatory surgery centers, ambulatory care centers and other outpatient settings, long-term care and assisted living facilities, home healthcare, other healthcare providers, healthcare payers, patients, pharmaceutical and biotechnology companies, medtech companies, and other end users.

How big is the global AI in telehealth & telemedicine market today?

The global AI in telehealth and telemedicine market is projected to grow from USD 4.22 billion in 2024 to USD 27.14 billion by 2030, at a compound annual growth rate (CAGR) of 36.4% from 2024 to 2030.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the AI in Telehealth & Telemedicine Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in AI in Telehealth & Telemedicine Market

DMCA.com Protection Status